Eisai
Price
Price
Historical dividends and forecast
Eisai has so far distributed $1.025 in 2024. The next dividend will be paid on 29.05.2025
CHART BY
Frequently asked questions
What is Eisai's market capitalization?
What is Eisai's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Eisai?
What are the analyst ratings and target price for Eisai's stock?
What is Eisai's revenue over the trailing twelve months?
What is the EBITDA for Eisai?
What is the free cash flow of Eisai?
What is the 5-year beta of Eisai's stock?
How many employees does Eisai have, and what sector and industry does it belong to?
What is the free float of Eisai's shares?
Financials
Market Cap
$8.95B5Y beta
0.31EPS (TTM)
$0.93Free Float
267.66MP/E ratio (TTM)
32.44Revenue (TTM)
$4.89BEBITDA (TTM)
$583.62MFree Cashflow (TTM)
-$251.38MPricing
Analyst Ratings
The price target is $47.31 and the stock is covered by 13 analysts.
Buy
6
Hold
4
Sell
3
Information
Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
11,067
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker